Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice
Go back to Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice| (NASDAQ: ACON) | Delayed: 2.45 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.45 | 52 Week High | $ | |||
| Open | $2.45 | 52 Week Low | $ | |||
| Day High | $2.45 | P/E | N/A | |||
| Day Low | $2.45 | EPS | $ | |||
| Volume | 1,254 | |||||
| (NASDAQ: ACONW) | Delayed: 0.02 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.02 | 52 Week High | $ | |||
| Open | $0.02 | 52 Week Low | $ | |||
| Day High | $0.02 | P/E | N/A | |||
| Day Low | $0.02 | EPS | $ | |||
| Volume | 1,254 | |||||

